168 related articles for article (PubMed ID: 37920834)
41. Diverse limbic comorbidities cause limbic and temporal atrophy in lewy body disease.
Sakurai K; Kaneda D; Morimoto S; Uchida Y; Inui S; Kimura Y; Cai C; Kato T; Ito K; Hashizume Y
Parkinsonism Relat Disord; 2022 Dec; 105():52-57. PubMed ID: 36368094
[TBL] [Abstract][Full Text] [Related]
42. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
[TBL] [Abstract][Full Text] [Related]
43. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
44. Differences of Behavioral and Psychological Symptoms of Dementia in Disease Severity in Four Major Dementias.
Kazui H; Yoshiyama K; Kanemoto H; Suzuki Y; Sato S; Hashimoto M; Ikeda M; Tanaka H; Hatada Y; Matsushita M; Nishio Y; Mori E; Tanimukai S; Komori K; Yoshida T; Shimizu H; Matsumoto T; Mori T; Kashibayashi T; Yokoyama K; Shimomura T; Kabeshita Y; Adachi H; Tanaka T
PLoS One; 2016; 11(8):e0161092. PubMed ID: 27536962
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease.
Zerr I; Villar-Piqué A; Hermann P; Schmitz M; Varges D; Ferrer I; Riggert J; Zetterberg H; Blennow K; Llorens F
Alzheimers Res Ther; 2021 Apr; 13(1):86. PubMed ID: 33883011
[TBL] [Abstract][Full Text] [Related]
46. Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study.
Perri R; Monaco M; Fadda L; Caltagirone C; Carlesimo GA
J Alzheimers Dis; 2014; 39(3):669-77. PubMed ID: 24254701
[TBL] [Abstract][Full Text] [Related]
47. Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?
Mc Ardle R; Galna B; Donaghy P; Thomas A; Rochester L
Alzheimers Dement; 2019 Oct; 15(10):1367-1377. PubMed ID: 31548122
[TBL] [Abstract][Full Text] [Related]
48. Dementia subtype and living well: results from the Improving the experience of Dementia and Enhancing Active Life (IDEAL) study.
Wu YT; Clare L; Hindle JV; Nelis SM; Martyr A; Matthews FE;
BMC Med; 2018 Sep; 16(1):140. PubMed ID: 30200957
[TBL] [Abstract][Full Text] [Related]
49. Clinical Lewy body dementia and the impact of vascular components.
Londos E; Passant U; Brun A; Gustafson L
Int J Geriatr Psychiatry; 2000 Jan; 15(1):40-9. PubMed ID: 10637403
[TBL] [Abstract][Full Text] [Related]
50. Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.
Chong JR; Chai YL; Lee JH; Howlett D; Attems J; Ballard CG; Aarsland D; Francis PT; Chen CP; Lai MK
J Alzheimers Dis; 2017; 56(1):157-166. PubMed ID: 27911312
[TBL] [Abstract][Full Text] [Related]
51. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
[TBL] [Abstract][Full Text] [Related]
52. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
Elder GJ; Mactier K; Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
Int J Geriatr Psychiatry; 2017 Nov; 32(11):1182-1189. PubMed ID: 28425185
[TBL] [Abstract][Full Text] [Related]
53. MRI identifies MCI subtypes: vascular versus neurodegenerative.
Meyer JS; Quach M; Thornby J; Chowdhury M; Huang J
J Neurol Sci; 2005 Mar; 229-230():121-9. PubMed ID: 15760630
[TBL] [Abstract][Full Text] [Related]
54. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
[TBL] [Abstract][Full Text] [Related]
55. Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.
Herbert MK; Aerts MB; Kuiperij HB; Claassen JAHR; Spies PE; Esselink RAJ; Bloem BR; Verbeek MM
Alzheimers Dement; 2014 Jul; 10(4):448-455.e2. PubMed ID: 24239248
[TBL] [Abstract][Full Text] [Related]
56. Influence of pneumonia complications on the prognosis of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and vascular dementia.
Manabe T; Mizukami K; Akatsu H; Teramoto S; Yamaoka K; Nakamura S; Ohkubo T; Kudo K; Hizawa N
Psychogeriatrics; 2016 Sep; 16(5):305-14. PubMed ID: 26510708
[TBL] [Abstract][Full Text] [Related]
57. Added Value of QEEG for the Differential Diagnosis of Common Forms of Dementia.
Livinț Popa L; Dragoș HM; Strilciuc Ș; Pantelemon C; Mureșanu I; Dina C; Văcăraș V; Mureșanu D
Clin EEG Neurosci; 2021 May; 52(3):201-210. PubMed ID: 33166175
[TBL] [Abstract][Full Text] [Related]
58. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
[TBL] [Abstract][Full Text] [Related]
59. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.
Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M
J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566
[TBL] [Abstract][Full Text] [Related]
60. Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies.
Tang W; Huang Q; Wang Y; Wang ZY; Yao YY
J Neurol Sci; 2014 Oct; 345(1-2):26-36. PubMed ID: 25086857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
